1 / 16

The Global Biobanking Equipment Marke Analysis| Coherent Market Insights

The Global Biobanking Equipment Market is expected to grow at CAGR of 7.5% during 2018 u2013 2026

shrutiCMI
Download Presentation

The Global Biobanking Equipment Marke Analysis| Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. BIO-BANKING EQUIPMENT MARKET ANALYSIS BiobankingEquipment Market,ByProduct Type (Equipment, Media, Consumables, and Others), By Sample Type (Human Tissue and Tumor Cells, Bio-Fluids, Stem Cells, Umbilical Cord, and DNA/RNA), By End User (Hospitals, Research Organization, Cell and Tissue Banks, Blood Banks, and DNA Banks) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, Outlook, and Opportunity Analysis, 2018-2026

  3. Market Insights • Biobanking is referred to a structured collections of biological samples, and associated data, stored for research purpose in future. The biobanks typically handle human biospecimens such as blood, tissue, and urine. They are established within academic medical or research institutions, pharmaceuticals or biotechnological companies or as a standalone organizations. Biobanks can be disease-oriented or population-based and they can contain a variety of samples such as blood, enzymes, organ tissue, urine, DNA, RNA, and cell lines. • The biobanks also help in precision medicine to discover several new treatments that are tailored for specific characteristic such as person’s genetic makeup or genetic profile of an individual tumor, which helps to transform the treatment. Precision medicine is effective in Alzheimer’s disease, arthritis, cardiovascular diseases, diabetes, oncology, psychiatric disorder, neurodegenerative disease, obesity, and pain.

  4. Furthermore, the biobanks are used to store the biological samples such as blood, cell lines, tissues, and DNA from patients with rare disease. For instance, Orphanet, the European portal for rare disease and orphan drugs developed a comprehensive disease coding systems and a database listing more than 100 rare disease biobanks in Europe. • The global biobanking equipment market was valued at US$ 1,778.3 million in 2017, and is expected to witness a robust CAGR of 7.5% over the forecast period (2018 – 2026).

  5. Market Growth • Increase in research and development in molecular biology and precision medicine is also expected to favor growth of the biobanking equipment market. In 2014, the Biobanking and BioMolecular resources Research Infrastructure–European Research Infrastructure Consortium (BBMRIERIC), an organization for biobanking in Europe, was established to provide a focal point for biobanking activities in Europe. It also provides access to quality-controlled human biological samples and associated data for cross-biobanking research.

  6. The biobanks also play a critical role in cancer research, as they provide access to the status of human genome. The complex networks of interactions between biomolecules and the clinical and functional consequences of their alteration can be studied on human genome instead of human biological specimens, which is easy for discovering new mechanisms involved in cancer. Biobanks are rapidly expanding in biomedical science domains including molecular pathology, molecular and genetic epidemiology, and pharmacogenomics.

  7. Market Restraints One of the major challenges in biobanking is to ensure an effective and ethical access to biological samples and associated clinical data. Trust between donors and researchers must be built so that individuals would like to donate to biobanks. Moreover, the stringent regulatory policy affects the biobanking equipment market, as the ‘The Privacy Rule’ (2002) established by U.S. Department of Health & Human Services have set new standards and regulations to protect the patients from inappropriate disclosures of their protected health information that may affect a patient's access to insurance, employability, and privacy.

  8. Regional Insights • On the basis of region, the global biobanking equipment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. In 2018, North America accounts for the largest revenue share in the global biobanking equipment market, followed by Europe. This is mainly attributed to increased awareness and initiatives related to precision medicine in the region. In 2015, the U.S. government announced the launch of Precision Medicine Initiative, which aimed to revolutionize the treatment to improve the health.

  9. Global Biobanking Equipment Market Share (%) Analysis, By Region, 2017

  10. Asia Pacific biobanking equipment market is expected to witness significant growth during the forecast period due to increasing biobanking related activities in the region. Asian countries, especially China, Japan, and Korea are very active in biobanking activities under the strategic plans coordinated by their governments. They also proactively established networks for biobanks of Asia to facilitate resource and expertise sharing. For instance, in 2014, for collection of human specimens, Japan’s Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Ministry of Health, Labor, and Welfare (MHLW) collaborated in managing human biobank networks of BioBank Japan (BBJ), National CenterBiobank Network (NCBN), and Tohoku Medical Megabank Organization (ToMMo) biobank project. • Furthermore, according to a study published by National Center for Biotechnology Information (NCBI), as of December 2015, the National Biobank of Korea (NBK), along with 17 regional biobanks of university hospitals and 2 network-affiliated hospitals, has collected human plasma, serum, DNA, and other specimens from 328,000 patients.

  11. Competitive Section Some of the major players operating in the global biobanking equipment market include Thermo Fisher Scientific Inc., BioLife Solutions, Inc., Beckman Coulter, Inc., Panasonic Biomedical Sales, BioCision, Taylor-Wharton International, VWR International, So-Low Environmental Equipment Co. and Tecan AG.

  12. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst Reference: https://www.coherentmarketinsights.com/market-insight/biobanking-equipment-market-2365

  13. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  14. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  15. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related